Joseph Lobacki

Joseph M.
Lobacki is currently an Independent Director at Sutro Biopharma, Inc. since 2017.
Formerly, Mr. Lobacki was President, Chief Executive Officer & Director at Artax Biopharma, Inc. from 2020 to 2024; Chief Commercial Officer & Executive Vice President at Verastem, Inc. from 2018 to 2019; Chief Operating Officer at Finch Research & Development LLC from 2016 to 2017; Chief Operating Officer at Finch Therapeutics Group, Inc. from 2013 to 2017; Chief Commercial Officer & Council Member at Medivation LLC (California) from 2014 to 2016; Independent Director at Jazz Pharmaceuticals Therapeutics, Inc. from 2013 to 2016; Chief Commercial Officer & Senior Vice President at Amgen Rockville, Inc. from 2011 to 2014; General Manager-Oncology Business at Idera Pharmaceuticals, Inc. from 2012 to 2014; Senior Vice President, General Manager-Transplant & Oncology at Genzyme Corp.
from 2003 to 2011.
Other former roles include Vice President-North American Marketing at SangStat Medical Corp., Vice President-Operations at Cell Pathways, Inc., and Chief Commercial Officer & Senior Vice President at Micromet, Inc. Education includes undergraduate degrees from Boston College in 1980 and Massachusetts College of Pharmacy & Health Science in 1983.